Middle East and Africa Protein Expression Market Drivers and Forecasts by 2028

The protein expression market in Middle East and Africa is expected to grow from US$ 106.0 million in 2021 to US$ 161.6 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

Five years ago, genomic sequencing was restricted to the research environment. Now, it is increasingly used in clinical practice, and over the next five years, genomic data from over 60 million patients is expected to be generated within healthcare. Genomic sequencing is rapidly transitioning into clinical practice, and its implementation into healthcare systems is supported by substantial government investments, totalling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives drive transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the growth of the protein expression market. In November 2018, Stilla Technologies announced the completion of a Series A financing round of US$ 18.3 million (€16 million) led by Illumina Ventures. The company will use the funds to commercialize its Naica digital PCR system and develop clinical applications. Thus, the continuous funding by the manufacturers and governments in genomics and proteomics is expected to create lucrative opportunities for the growth of the protein expression market in the coming years. 

COVID-19 pandemic has become the most significant challenge in the region. This challenge will be especially frightening for the region’s fragile and conflict-torn states—such as Iraq, Sudan, Iran, Israel and Yemen as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable shortage of them. The Middle East countries have registered a growth in the number of COVID cases in the last few days. However, demand for protein expression systems in this pandemic is inclined from the outbreak of Covid-19, but now the pharma companies are working on developing strategies to develop and manufacture the required reagents, instruments for the research of vaccine fulfill the demands of protein expression. The demand of protein expression in the region is expected to increase due to the rising Covid-19 cases and other diseases such as cancer.  The impact of the COVID19 pandemic on the regional protein expression market is moderate.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the protein expression market. The Middle East and Africa protein expression market is expected to grow at a good CAGR during the forecast period.

Middle East and Africa Protein Expression Market Segmentation         

By Product

• Competent Cells
• Expression Vectors
• Reagents
• Instruments

By Services

• Antibody Development & Production
• Protein Expression & Production
• Hybridoma One-Stop Services
• Stable Cell Line Development
• Bioanalytical Assay Services

By Application

• Research
• Therapeutic
• Industrial

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Others

By Country

• Middle East and Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned

• Thermo Fisher Scientific Inc.
• GenScript
• Merck KGaA
• Takara Bio Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN
• New England Biolabs
• Promega Corporation

Middle East and Africa Protein Expression Report Scope